Translational Development Acquisition Corp. · NASDAQ:TDAC
Wolverine Asset Management LLC's stake in Translational Development Acquisition Corp. fell to 4.89% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 16, 2026
Wolverine Asset Management LLC's stake in Translational Development Acquisition Corp. fell to 4.89%, 944,878 shares, as a passive investor on Jun 30, 2026. Filed Jul 16, 2026 (Schedule 13G/A).
- Stake
- 4.89%
- Shares
- 944,878
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wolverine Asset Management, LLC | 4.89% | 944,878 |
| Wolverine Holdings, LLC | 4.89% | 944,878 |
| Christopher L. Gust | 4.89% | 944,878 |
| Robert R. Bellick | 4.89% | 944,878 |
Source
Related
- Translational Development Acquisition Corp.
- Wolverine Asset Management LLC
- Translational Development Acquisition Corp. shareholders
- Schedule 13G/A · Wolverine Asset Management LLC · Oct 10, 2025
- Schedule 13G/A · Wolverine Asset Management LLC · Jul 11, 2025
- Schedule 13G · Wolverine Asset Management LLC · May 1, 2025
- Schedule 13G/A · Linden Advisors LP · Aug 14, 2026
- Schedule 13G · Meteora Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · Aug 12, 2026
- Schedule 13G · Linden Advisors LP · Jun 2, 2026
- Schedule 13G · Goldman Sachs Group Inc · May 13, 2026